2020 U.S.-Booked Air Volume: $23.8 million
2020 U.S.-booked air spending volume for pharmaceutical and medical device provider Abbott came in at $23.8 million—less than one-quarter of the company’s 2019 volume, according to a BTN estimate. While its own travel activity declined sharply, the company has been active in the larger travel industry with its BinaxNow home Covid test playing a key role in self-administered testing initiatives from air carriers including American Airlines and United Airlines.
The company’s global revenue ticked up to $34.6 billion in 2020, an 8 percent increase from 2019, while net corporate earnings surged 22 percent to $4.5 billion over the same period, continuing a three-year run of strong net earnings growth. Abbott employed a workforce of about 109,000 as of Dec. 31, 2020, an increase of about 2,000 from a year prior.